.2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 -
ANSWER-use BP lowering meds
.2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD
- ANSWER-initiate therapy with thiazide diuretic or CCB
.2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 -
ANSWER-use BP lowering meds
.2017 ACC/AHA guidelines: drugs contraindicated in pregnant
women - ANSWER-- ACE
- ARBs
- direct renin inhibitors
.2017 ACC/AHA guidelines: elevated BP - ANSWER-120-129/
<80
,.2017 ACC/AHA guidelines: elevated BP reassessment -
ANSWER-3-6 months
.2017 ACC/AHA guidelines: first line agents - ANSWER-- thiazide
diuretics
- CCBs
- ACE
- ARBs
.2017 ACC/AHA guidelines: HTN reassessment for new or
adjusted drug regimen - ANSWER-follow up at monthly intervals
until control is sustained
.2017 ACC/AHA guidelines: hypertensive crisis - ANSWER->
180/120
admit to ICU if target organ damage
, .2017 ACC/AHA guidelines: hypertensive URGENCY - ANSWER-
- elevated BP without current organ damage
- happens when patients stop taking their meds
- doesn't require a rapid decrease
- check proteinuria and BMP
- one week follow up
.2017 ACC/AHA guidelines: initiation of drug therapy in stage 1
HTN - ANSWER-initiate therapy with a single drug
.2017 ACC/AHA guidelines: initiation of drug therapy in stage 2
HTN - ANSWER-initiate drug therapy with 2 first line medications
of different classes as separate agents or combo drug
.2017 ACC/AHA guidelines: no CVD and ASCVD risk < 10% BP
threshold - ANSWER-≥ 140/90
.2017 ACC/AHA guidelines: normal BP - ANSWER-<120 / <80